In the Curtis dataset, which contains microarray data for 1508 ER+ breast cancer patients [39], we stratified ER+ breast cancer patients into a good (alive after 10 years) and poor (death due to disease before 10 years) prognosis group with 387 and 293 patients, respectively. Here, ESR1 is linked to breast carcinoma.